326 related articles for article (PubMed ID: 25885112)
1. Pharmacokinetics of nalbuphine hydrochloride extended release tablets in hemodialysis patients with exploratory effect on pruritus.
Hawi A; Alcorn H; Berg J; Hines C; Hait H; Sciascia T
BMC Nephrol; 2015 Apr; 16():47. PubMed ID: 25885112
[TBL] [Abstract][Full Text] [Related]
2. A pramoxine-based anti-itch lotion is more effective than a control lotion for the treatment of uremic pruritus in adult hemodialysis patients.
Young TA; Patel TS; Camacho F; Clark A; Freedman BI; Kaur M; Fountain J; Williams LL; Yosipovitch G; Fleischer AB
J Dermatolog Treat; 2009; 20(2):76-81. PubMed ID: 18821119
[TBL] [Abstract][Full Text] [Related]
3. Gabapentin in the treatment of uremic itch: an index case and a pilot evaluation.
Manenti L; Vaglio A; Costantino E; Danisi D; Oliva B; Pini S; Prati E; Testori A
J Nephrol; 2005; 18(1):86-91. PubMed ID: 15772928
[TBL] [Abstract][Full Text] [Related]
4. Garenoxacin pharmacokinetics in subjects with renal impairment.
Krishna G; Gajjar D; Swan S; Marbury T; Grasela DM; Wang Z
Curr Med Res Opin; 2007 Mar; 23(3):649-57. PubMed ID: 17355746
[TBL] [Abstract][Full Text] [Related]
5. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Nalbuphine ER Tablets for Uremic Pruritus.
Mathur VS; Kumar J; Crawford PW; Hait H; Sciascia T;
Am J Nephrol; 2017; 46(6):450-458. PubMed ID: 29253847
[TBL] [Abstract][Full Text] [Related]
6. Single- and multiple-dose pharmacokinetics of a hydrocodone bitartrate extended-release tablet formulated with abuse-deterrence technology in healthy, naltrexone-blocked volunteers.
Darwish M; Yang R; Tracewell W; Robertson P; Bond M
Clin Ther; 2015 Feb; 37(2):390-401. PubMed ID: 25542074
[TBL] [Abstract][Full Text] [Related]
7. Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies.
Wikström B; Gellert R; Ladefoged SD; Danda Y; Akai M; Ide K; Ogasawara M; Kawashima Y; Ueno K; Mori A; Ueno Y
J Am Soc Nephrol; 2005 Dec; 16(12):3742-7. PubMed ID: 16251241
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacokinetics of gabapentin after administration of gabapentin enacarbil extended-release tablets in patients with varying degrees of renal function using data from an open-label, single-dose pharmacokinetic study.
Lal R; Sukbuntherng J; Luo W; Chen D; Blumenthal R; Ho J; Cundy KC
Clin Ther; 2012 Jan; 34(1):201-13. PubMed ID: 22206794
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive- extended-release and immediate-release tablets: a randomized, open-label, multiple-dose, three-way crossover, exploratory study in healthy subjects.
Gordi T; Hou E; Kasichayanula S; Berner B
Clin Ther; 2008 May; 30(5):909-16. PubMed ID: 18555937
[TBL] [Abstract][Full Text] [Related]
10. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA
Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
[TBL] [Abstract][Full Text] [Related]
11. Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients.
Balaskas EV; Bamihas GI; Karamouzis M; Voyiatzis G; Tourkantonis A
Nephron; 1998; 78(4):395-402. PubMed ID: 9578065
[TBL] [Abstract][Full Text] [Related]
12. Elevated interleukin 31 serum levels in hemodialysis patients are associated with uremic pruritus.
Oweis AO; Al-Qarqaz F; Bodoor K; Heis L; Alfaqih MA; Almomani R; Obeidat MA; Alshelleh SA
Cytokine; 2021 Feb; 138():155369. PubMed ID: 33221158
[TBL] [Abstract][Full Text] [Related]
13. Single-dose linezolid pharmacokinetics in critically ill patients with impaired renal function especially chronic hemodialysis patients.
El-Assal MI; Helmy SA
Biopharm Drug Dispos; 2014 Oct; 35(7):405-16. PubMed ID: 25044219
[TBL] [Abstract][Full Text] [Related]
14. Cromolyn sodium: a potential therapy for uremic pruritus?
Rosner MH
Hemodial Int; 2006 Apr; 10(2):189-92. PubMed ID: 16623673
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic evaluation of tapentadol extended-release tablets in healthy subjects.
Zannikos PN; Smit JW; Stahlberg HJ; Wenge B; Hillewaert VM; Etropolski MS
J Opioid Manag; 2013; 9(4):291-300. PubMed ID: 24353023
[TBL] [Abstract][Full Text] [Related]
16. Clinical interpretation of the Uremic Pruritus in Dialysis Patients (UP-Dial) scale: a novel instrument for the assessment of uremic pruritus.
Nochaiwong S; Ruengorn C; Koyratkoson K; Chaisai C; Awiphan R; Thavorn K; Noppakun K; Suteeka Y; Panyathong S; Chongruksut W; Nanta S; Chiewchanvit S;
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1188-1194. PubMed ID: 28960570
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of a novel ĸ-agonist for managing intractable pruritus in dialysis patients.
Kumagai H; Ebata T; Takamori K; Miyasato K; Muramatsu T; Nakamoto H; Kurihara M; Yanagita T; Suzuki H
Am J Nephrol; 2012; 36(2):175-83. PubMed ID: 22868684
[TBL] [Abstract][Full Text] [Related]
18. Steady-state pharmacokinetics and tolerability of orally administered fampridine sustained-release 10-mg tablets in patients with multiple sclerosis: a 2-week, open-label, follow-up study.
Vollmer T; Blight AR; Henney HR
Clin Ther; 2009 Oct; 31(10):2215-23. PubMed ID: 19922892
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
20. Effect of depot oral cholecalciferol treatment on secondary hyperparathyroidism in stage 3 and stage 4 chronic kidney diseases patients.
Dogan E; Erkoc R; Sayarlioglu H; Soyoral Y; Dulger H
Ren Fail; 2008; 30(4):407-10. PubMed ID: 18569914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
